Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Norman Sharpless to Serve as Interim FDA Commissioner | Contract Pharma

What are you searching for?

Sign in
Breaking News

Norman Sharpless to Serve as Interim FDA Commissioner

The process of searching for a permanent replacement to Dr. Gottlieb is underway

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma


 
Norman Sharpless, National Cancer Institute Director, will serve as acting commissioner of the FDA, succeeding Scott Gottlieb, who is leaving early April. Dr. Sharpless, an accomplished researcher, oncologist and administrator, was appointed to head the institute, part of NIH, in June 2017. The process of searching for a permanent replacement to Dr. Gottlieb is underway.
 
Dr. Sharpless was director of the University of North Carolina’s Lineberger Comprehensive Cancer Center, which is part of the National Institutes of Health. He is one of the founders of G1 Therapeutics, a clinical-stage biopharmaceutical company developing novel, small-molecule therapies to treat cancer, and a founder of Sapere Bio (formerly HealthSpan Diagnostics), a clinical-phase biotechnology company measuring physiologic reserve to improve healthcare.
 
Dr. Gottlieb said he is resigning to spend more time with his family. Dr. Gottlieb became commissioner in May 2017, and during his tenure, worked to foster competition and reduce the cost and availability of both brand and generic medicines. In his first year as commissioner, a record number of new and generic drugs were approved.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters